Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Orphan-paediatric
Orphan-paediatric
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan-paediatric
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
Orphan-paediatric
Studies Show Sarepta’s Exondys 51 Slows Respiratory Decline in Muscular Dystrophy Patients
Orphan-paediatric
Novartis reports positive interim Phase III data for Zolgensma gene therapy candidate in SMA type 1
Orphan-paediatric
Industry and Advocacy Groups Urge FDA to Allow More Real-World Data for Rare Disease Trials
Orphan-paediatric
Axovant Releases Positive Interim Updates for Parkinson’s and Tay-Sachs Gene Therapy Trials
Orphan-paediatric
ArQule Announces Publication of Clinical Data with Miransertib in Proteus Syndrome
Biospace News
-
February 25, 2019
0
Orphan-paediatric
Drug for children with spinal muscular atrophy too expensive, HSE says ...
Firstwordpharma News
-
February 22, 2019
0
Orphan-paediatric
FDA Grants Priority Review and Accepts sBLA of SOLIRIS (Eculizumab) as...
Firstwordpharma News
-
February 22, 2019
0
Orphan-paediatric
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2...
Firstwordpharma News
-
February 21, 2019
0
Orphan-paediatric
Deloitte Predicts Pharma Growth Driven by Orphan Disease Drugs and External...
Biospace News
-
February 20, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
MOST POPULAR
RI Bio Interview: Rhode Island Sets the Stage for Long-Term Life...
July 17, 2019
ICER Posts Draft Scoping Document for the Assessment of Treatments for...
May 2, 2019
A Deeper Look at Drug Shortages in the U.S.
February 1, 2019
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
May 13, 2019
Load more
HOT NEWS
Immuno-oncology
Bayer, Janssen and BMS Unveil Promising Data for Prostate Cancer at...
Dermatology
Asana BioSciences to Present Correlation Between Microbiome Changes and Clinical Efficacy...
Others
nference Enters into an R&D Data Science Strategic Partnership with Janssen
Phase III
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
